Nanotechnology News and Research

RSS

IBN’s green tea-based drug nanocarriers show superior tumor-killing performance

The Institute of Bioengineering and Nanotechnology of A*STAR has reported superior results using new green tea-based nanocarriers to kill liver cancer cells, compared to existing drug delivery systems.

16 Mar 2018

New class of antimicrobial polymers can kill five hard-to-treat multidrug-resistant bacteria

An international research team led by the Institute of Bioengineering and Nanotechnology of the Agency for Science, Technology and Research and IBM Research developed a synthetic molecule that can kill five deadly types of multidrug-resistant bacteria with limited, if any, side effects.

7 Mar 2018

New study shows advantages of DNA barcoding technique for identifying nanoparticles

The first direct comparison of in vitro and in vivo screening techniques for identifying nanoparticles that may be used to transport therapeutic molecules into cells shows that testing in lab dishes isn't much help in predicting which nanoparticles will successfully enter the cells of living animals.

5 Mar 2018

Home-based semen analysis kit could provide rapid, cost-effective way to test male fertility

It is estimated that of the 70 million cases of infertility worldwide, almost half are caused by factors relating to the male partner. A number of semen parameters – motility, morphology, velocity, volume, concentration, and count – affect male fertility.

28 Feb 2018

Researchers create minuscule, light-powered wires to modify electrical signaling between neurons

The human brain largely remains a black box: How the network of fast-moving electrical signals turns into thought, movement and disease remains poorly understood. But it is electrical, so it can be hacked--the question is finding a precise, easy way to manipulate electrical signaling between neurons.

21 Feb 2018

Specialized nanotechnology could reduce pain, recovery time in oral surgery

A trip to the dentist or orthodontist usually instills a sense of dread in most patients, and that's before the exam even begins. Add to that the fear of oral surgery with a painful recovery, and many people will avoid these visits at all costs.

14 Feb 2018

Researchers use upconversion nanoparticles to understand brain functions

Scientists from the National University of Singapore have worked with an international research team to jointly develop a novel approach for deep brain stimulation.

14 Feb 2018

Using Smartphones for Cancer Diagnosis and Management

Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a “less is more” approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro’s research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.

From Pittcon 14 Feb 2018

Scientists design nanorobots that seek and destroy tumor cells

Scientists have successfully programmed nanorobots to target and shrink tumors by cutting off their blood supply, whilst leaving healthy tissue untouched.

13 Feb 2018

Scientists program nanorobots to shrink tumors

In a major advancement in nanomedicine, Arizona State University scientists, in collaboration with researchers from the National Center for Nanoscience and Technology, of the Chinese Academy of Sciences, have successfully programmed nanorobots to shrink tumors by cutting off their blood supply.

12 Feb 2018

Researchers develop antimicrobial plastic films to reduce infection risk in hospitals

In the framework of the European project FLEXPOL, members of the UA NANOBIOPOL group are designing formulations with antimicrobial properties from essential oils.

9 Feb 2018

Biomedical engineers develop miniature self-sealing wound model

Biomedical engineers have developed a miniature self-sealing model system for studying bleeding and the clotting of wounds. The researchers envision the device as a drug discovery platform and potential diagnostic tool.

8 Feb 2018

New modular platform offers robust biological approach that targets endless number of diseases

The biological complexity of cancer and other diseases demands a more formidable arsenal of therapies than currently available. Most therapeutic approaches ignore the dynamic molecular network of genes, targeting instead only very few selected disease-related genes.

1 Feb 2018

UL scientists and EI team up to tackle biggest challenge of pharmaceutical industry

Scientists at University of Limerick are teaming up with Enterprise Ireland to commercialize continuous nanomanufacturing technology which promises to transform the pharmaceutical market.

30 Jan 2018

BioAxial receives US patent for new ‘black fluorophore’ technology

BioAxial, a key player in live cell super resolution microscopy, today announces that it has been granted a US patent covering ‘black fluorophore’, a pivotal component of ‘dark tracking’ technology. This patent consolidates BioAxial’s patent portfolio, which already comprises ten patent families. It also strengthens the company’s position as a technology leader in the field of commercial super-resolution imaging modules.

24 Jan 2018

BIST researchers develop new retinal prosthesis to address visual degeneration

A healthy retina contains photoreceptor cells that convert light changes into nerve impulses, which are then carried along the optic nerve to the brain, where they are decoded into images. Diseases such as retinitis pigmentosa cause the photoreceptor cells to stop functioning, while the rest of the eye remains healthy.

24 Jan 2018

Study highlights new long-acting approach for prevention of malaria

A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

22 Jan 2018

Administration of two proteins shown to counteract neurodegeneration in Parkinson's disease

A combination therapy made up of two neurotrophic factors can reduce the degenerative effects of Parkinson’s disease, shows new research.

15 Jan 2018

Synergy between two neurotrophic factors exerts beneficial effect in early phase of Parkinson’s disease

Parkinson's disease is currently the second most widespread neurogenerative pathology. Current therapies are mainly of a replacement type and pose problems in the long term, so the challenge is to establish an early diagnosis and develop neuroprotective and neurorestorative therapies that will allow the symptoms of the disease to be slowed down or even reversed.

12 Jan 2018

UC scientists identify protein that acts as mediator of HER2-driven breast cancer

Researchers at the University of Cincinnati College of Medicine have identified for the first time that the estrogen receptor-binding protein MED1 is a critical mediator of HER2-driven breast cancer, identifying it as a potential therapeutic target.

9 Jan 2018